Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMedOpen access

Neuro-immune-vascular-stem cell crosstalk in bone/cartilage regeneration: mechanisms, technological advances, and clinical perspectives.

Liu Z., Fan H., Yang Y.

Narrative Review on Cartilage Damage, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Bioeng Biotechnol (2026)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
41993713
PMCID
PMC13080096
DOI
10.3389/fbioe.2026.1778578
Citations
1

Abstract (original English)

Functional regeneration of bone and cartilage remains an urgent clinical challenge in orthopedics, as its repair process involves the synergistic participation of multiple systems and cell types. Traditional studies have mostly focused on the regulatory roles of individual cells or signaling pathways, while recent research has confirmed that bone/cartilage regeneration is governed by a regulatory mechanism centered on the neuro-immune-vascular axis. In this mechanism, mesenchymal stem cells (MSCs), bone marrow mesenchymal stem cells (BMSCs), adipose-derived mesenchymal stem cells (ADSCs), and cartilage progenitor cells (CPCs) serve as key functional cells, interacting sequentially and transcellularly with immune cells and endothelial cells through multiple core signaling pathways. This review systematically summarizes these core signaling pathways, including neurosignal-mediated pathways (CGRP/ CRLR , NGF / TrkA , SP/ NK1R ), immune signal-mediated pathways ( IL-4 / IL-4R , TGF-β /Smad, TNF-α / NF-κB ), endothelial cell-mediated pathways ( VEGF / VEGF R, Notch, PDGF / PDGF R), and cross-regulatory pathways ( PI3K / Akt , MAPK ). These pathways collectively mediate the sequential crosstalk and functional coordination among the four cellular components. Additionally, the review highlights the application achievements of cutting-edge technologies in this field, such as single-cell

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research